Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention

NCT06281834 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pediatric HIV Infection
Latent Tuberculosis

Interventions

DRUG: Rifapentine
DRUG: Dolutegravir

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]